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Abstract (J Korean Assoc Oral Maxillofac Surg 2013;39:246-250)
Rhinocerebral mucormycosis (RCM) is an opportunistic, potentially life-threatening fungal disease. This infective disease invades not only the facial 
sinuses, but also the maxilla, zygoma, and rhino-cerebral structures with a massive destruction of the facial skeletons and soft tissue. This disease 
progresses within various underlying diseases, such as diabetes mellitus, hematologic malignancy, renal failure, and systemic immunodepression. The 
relationship between mucormycosis and these underlying conditions have been discussed extensively in the literature. The authors studied 6 cases of 
RCM diagnosed by a tissue biopsy and treated at the department of oral and maxillofacial surgery, from 1997 to 2012. Patients were treated with sever-
al kinds of surgical interventions and antifungal agents, and their clinical & radiological signs, underlying conditions, surgical methods, and outcomes 
were analyzed.
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hyposmia, and anosmia have also been described as typical 
symptoms of the disease2.
This study sought to present a series of cases involving 
six patients diagnosed with RCM and treated with several 
methods, consider the prevalence and mortality factors, and 
analyze each case with reference to related articles.
II. Case Report
Six patients diagnosed with RCM based on tissue biopsy 
and treated in several conservative and surgical ways in 
our department between the years 1997-2012 were studied 
retrospectively. Their clinical symptoms, imaging findings, 
underlying diseases, surgical methods, and time consumed 
from the first visit to our department to the first medical and 
surgical interventions were analyzed and discussed.
The six patients, whose average age was 65.0 years (49-
74 years), were diagnosed with mucormycosis in the oral and 
maxillofacial areas based on tissue biopsy.(Table 1) Facial 
swelling (n=3; 50%) and headache (n=3; 50%) were the most 
common symptoms, followed by hypoesthesia (n=2; 33.3%). 
Maxillary sinus was involved most frequently (n=5; 83.3%), 
followed by sphenoid and ethmoid sinus (n=2; 40%) and 
I. Introduction
Mucormycosis is known as a life-threatening fungal dis-
ease that destroys hard and soft tissue especially within vari-
ous predisposing underlying conditions. Among five subtypes 
(rhinocerebral, pulmonary, intestinal, cutaneous, and dissemi-
nated), rhinocerebral mucormycosis (RCM) is a rare, fatal, 
opportunistic subtype invading the oral and maxillofacial ar-
eas including facial sinuses, maxilla, zygoma, orbit, and oral 
cavity. Clinical signs include facial cellulitis, orbital swelling, 
black necrotic palate, and facial (VII) and/or trigeminal (V) 
nerve involvement1. Nasal obstruction or congestion with 
noisy breathing, headache, odontalgia, sinusitis with low-
grade fever and unilateral facial swelling, maxillary pain, 
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discharged without any mortality, they had started to be treat-
ed in the department of prosthodontics for the restoration of 
their appearance and function.
We present in detail the case of one patient, a 72-year-old 
male who had the most aggressive oral-maxillofacial involve-
ment including several facial bones. His had several underly-
ing diseases as seen in Table 1. He was first referred to our 
department with left maxillary gingival pain and suborbital 
swelling that had started about 10 days before the first visit. 
The clinical examination revealed generalized swelling and 
tenderness on the left mid-face with intraoral fistula in the left 
maxillary vestibule. The facial computed tomography imag-
ing showed extensive invasion of the left maxillary sinus and 
other facial bones, making extensive sequestrum at the left 
maxilla, zygoma, nasal bone, floor of orbit, and maxillary 
alveolar bone.(Fig. 1) With OM presumed in the above area, 
the patient underwent sequestrectomy of the left maxilla, 
zygoma, alveolar bone, and extraction of the teeth involved. 
After being diagnosed with RCM based on tissue biopsy (Fig. 
2), he was referred to the department of infectious diseases 
for systemic antifungal treatment, receiving AmB, liposomal 
amphotericin, and posaconazole. Post-operation wound heal-
ing was favorable, and temporary acute renal failure was cor-
rected immediately.
floor of orbit (n=2; 40%).
Five patients (patient numbers 1, 2, 3, 4, 5) had diabetes mel-
litus (DM) as an underlying disease (n=5; 83.3%). These pa-
tients with DM had surgical intervention and antifungal therapy 
(amphotericin B [AmB] or liposomal amphotericin B [L-AmB] 
or posaconazole); one patient (patient number 6) had polyene 
gargle treatment only without surgery. Antifungal medica-
tion was basically initiated with AmB up to 2.0 g. Monitoring 
nephrotic values such as level of serum blood urea nitrogen or 
creatinine and calculating accumulative dose, medications were 
changed to L-AmB or posaconazole.
Surgical methods were sequestrectomy of the involved 
maxilla, zygoma, and floor of orbit, ethmoid-sphenoidecto-
my, Caldwell-Luc operation, and antrostomy. Most of our 
patients (patient numbers 2, 3, 4, 5) had surgery under the 
impression of osteomyelitis (OM) as their clinical and radio-
logical aspects. Final reports of the pathologic report enabled 
us to assure the RCM of four patients 2-7 days after the 
major surgery. The other patient (patient number 1), as we 
mentioned above, had final diagnosis of RCM based on tissue 
biopsy 2 days before he had surgery, i.e., ethmoid-sphenoid-
ectomy. After the surgical intervention, they were referred to 
the Department of Infectious Diseases at Severance Hospital 
for intensive antifungal treatment. Before all patients were 
Table 1. Summary of rhinocerebral mucormycosis patient data
No. of
patient 
Age
(yr)
Sex Clinical symptom Underlying disease Imaging finding Surgical method
1st visit- 
surgical 
operation 
(day)
1st visit-
antifungal 
medication 
(day)
1
2
3
4
5
6
49
74
72
67
71
57
M
F
M
M
M
F
Facial swelling, hy po-
e sthesia, headache, 
general toothache
Facial swelling, fever, 
headache
Facial swelling, 
intra oral fistula
Headache, fever, 
tris mus, diplopia
General toothache, 
hy poesthesia
Non-symptomatic mass 
on soft palate
DM
Renal failure
Meningitis
DM
Hepatitis B
Hypertension
DM, MI
Angina pectoris
Arteriosclerosis
S/P PTCA
d/t CAOD
DM
DM
Aplastic anemia
Angina pectoris
Pyelonephritis
Right maxillary, sphenoidal, 
ethmoidal sinus
Left maxillary sinus
Nasal cavity
Alveolar bone
Left maxillary, ethmoidal, 
sp henoidal sinus, left 
zy goma, nasal bone, floor
of orbit, alveolar bone
Left maxillary sinus
Acute orbital cellulitis
Right lateral pterygoid 
muscle, temporalis muscle, 
and prezygomatic subcuta-
neous space abscess
Right maxillary sinus
Right floor of orbit
-
Ethmoid-sphenoi-
dectomy
Sequestrectomy
Sequestrectomy
Caldwell-Luc 
ope ration
Antrostomy
Sequestrectomy
-
12
40
24
40
 7
-
11
42
43
45
28
12
(M: male, F: female, DM: diabetes mellitus, MI: myocardial infarction, S/P: status post, PTCA: percutaneous transluminal coronary angioplasty, 
d/t: due to, CAOD: coronary artery occlusive disease)
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Fig. 1. A. Preoperation computed tomography (CT) axial view: presenting involvement of left maxilla, zygoma and severe mucosal thicken-
ing on both maxillary sinus. B. Preoperation CT axial view: presenting involvement of maxilla, left maxillary sinus; and increased bony scle-
rosis in the medullary portion of left maxilla. C. Preoperation CT frontal view: presenting involvement of left maxilla, zygoma, floor of orbit, 
ethmoidal, sphenoidal sinus, nasal cavity, alveolar bone. Arrows indicate the border of the lesion.
Jin-Geun Kim et al: Importance of immediate surgical intervention and antifungal treatment for rhinocerebral mucormycosis: a case report. J Korean Assoc Oral Maxillofac Surg 2013
Fig. 2. Histological view of rhinocerebral mucormycosis. A. Peri-
odic acid-Schiff (PAS) staining, ×200. B. H&E staining, ×200. C. 
Grocott’s methenamine silver (GMS) staining, ×200. Arrows and 
arrowheads in the figures show aseptate hyphae branching at 
90o.
Jin-Geun Kim et al: Importance of immediate surgical intervention and antifungal treat-
ment for rhinocerebral mucormycosis: a case report. J Korean Assoc Oral Maxillofac 
Surg 2013
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the prevalence and mortality risk factors of mucormycosis 
are not the same, we should approach the prevention and 
treatment of mucormycosis independently. All six patients in 
our cases survived regardless of whether they had surgical in-
tervention (n=5) or not (n=1). This high survival rate is sug-
gestive, considering other studies reporting high mortality of 
RCM. Though 83% (n=5) of the patients had DM, all of them 
were in a course of proper care. We evaluated that no one had 
hematologic malignancy, which was an important factor for 
the low mortality in this report.
The efficacy and proper dosage of AmB have been re-
producibly demonstrated in both laboratory (in vitro and in 
vivo) investigations and in clinical studies12-16, and there is a 
report of delayed AmB-based therapy resulting in 2-fold in-
crease in mortality rate12. The L-AmB formulation has better 
penetration into cerebral tissue than other agents; hence its 
potentially better efficacy in cases of rhinocerebral involve-
ment15. Furthermore, posaconazole, combination therapy with 
echinocandins and defarasirox, and hyperbaric oxygen can be 
used as adjunctive therapy in the management of mucormy-
cosis14. 
Surgical debridement is fundamental for the successful 
management of most cases of RCM. Using less aggressive 
surgical procedures with combined medication may enhance 
survival from oral and maxillofacial mucormycosis14. The 
general impression of intra-operative finding was similar to 
that of OM as well as clinical/radiological features. There 
was necrotic bone with sequestrum, with some granulation 
tissue with pus discharge in the structures involved. Note, 
however, that there was extensive spreading of the lesions 
even to the frontal process of maxilla close to the orbit, com-
pared with the OM we used to experience. 
We spent 24.6 days and 30.2 days on the average from the 
first visit to surgical intervention and commencement of an-
tifungal mediation. Despite the difficult diagnosis of RCM, 
shortening the time to start antifungal medication and surgi-
cal intervention were thought to be the most important factors 
for the high survival rate in our study. The authors performed 
surgical/medical interventions on oral and maxillofacial mu-
cormycosis patients with variable underlying diseases and 
reported high survival rate of the cases.
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